ToolGen Inc.

Company Overview

ToolGen is a genome-editing company focused on translating genetic knowledge into transformative products for biomedicine and agriculture. The company creates and holds intellectual property rights for essential tools and technologies for editing the genetic information in microbial, plant, animal, and human cells.

ToolGen was founded in 1999 by Dr. Jin-Soo Kim (currently a director at Genome Engineering Center, Institute of Basic Sciences, Korea) to develop genetic tools based on zinc-finger engineering technology to modulate the use of genes in cells, which, in turn, lead to the invention of a series of engineered nucleases including zinc-finger nucleases, TAL effector nucleases and, most recently, CRISPR-Cas9 nucleases.

ToolGen’s mission is to focus on translating breakthrough genome editing technology into innovative products that will improve various aspects of human lives. The company aims to develop genome-editing therapeutics to improve the outcome of severe diseases with unmet medical needs and to develop genome-edited crops and animals with beneficial traits as well. ToolGen is seeking to not only improve the genome-editing platform to enable more accurate and efficient editing of genetic information, but also integrate other current cutting-edge technologies in biomedicine and agriculture with its core genome editing platforms. The company is collaborating and establishing strategic alliances with academia and companies in research, agriculture, and therapeutics.

Financial Highlights (FY 2023)

Company's Business Segments

• Genome Editing Technology : The company provides gRNA/Cas9 purified, gRNA/Cas9, and recombinant Cas9 protein, which offers ready-to-use reagents for genome engineering experiments.